Β3-adrenoceptor function and long-term changes in body weight

Β3-adrenoceptor function and long-term changes in body weight


Play all audios:

Loading...

ABSTRACT BACKGROUND: The endogenous factors contributing to long-term changes in body weight are not known but the regulation of energy metabolism by different beta-adrenoceptors (β1-AR,


β2-AR, β3-AR) or alpha-adrenoceptors (α2-AR) may play a role. METHODS: In a prospective study, we investigated β-AR and α2-AR subtype function in subcutaneous fat cells of 85 healthy,


non-obese women by using a standardized bioassay of lipolysis. Of these 73 were re-investigated on an average 10 years later to compare baseline function of β1-AR, β2-AR, β3-AR and α2-AR


with longitudinal weight changes. RESULTS: Weight change over time was normally distributed ranging from−4 kg/m2 to +6 kg/m2 in body mass index. Long-term changes in body weight correlated


inversely with β3-AR function at base line (_r_=0.5, _P_=0.001). Those with low β3−AR function gained weight, whereas the opposite was observed with those who had a high β3-AR function.


Nineteen percent of weight changes could be explained by β3-AR status. No relationship with weight changes was observed as regards the function of α2-AR, β1-AR or β2-AR function.


CONCLUSIONS: β3-ARs are important for long-term changes in body weight putting energy metabolism in adipose tissue in frontline among endogenous factors that regulate body weight in


adulthood. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to


this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy


now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact


customer support SIMILAR CONTENT BEING VIEWED BY OTHERS LEPTIN ALTERS ENERGY INTAKE AND FAT MASS BUT NOT ENERGY EXPENDITURE IN LEAN SUBJECTS Article Open access 13 October 2020 METABOLIC


SURGERY-INDUCED CHANGES OF THE GROWTH HORMONE SYSTEM RELATE TO IMPROVED ADIPOSE TISSUE FUNCTION Article Open access 23 March 2023 FACTORS ASSOCIATED WITH BODY WEIGHT GAIN AND


INSULIN-RESISTANCE: A LONGITUDINAL STUDY Article Open access 22 April 2024 REFERENCES * James WP . The epidemiology of obesity: the size of the problem. _J Intern Med_ 2008; 263: 336–352.


Article  CAS  Google Scholar  * He XZ, Baker DW . Changes in weight among a nationally representative cohort of adults aged 51–61, 1992–2000. _Am J Prev Med_ 2004; 27: 8–15. Article  Google


Scholar  * Stubbs CO, Lee AJ . The obesity epidemic: both energy intake and physical activity contribute. _Med J Aust_ 2004; 181: 489–491. PubMed  Google Scholar  * Bouchard C, Tremblay A,


Despres JP, Nadeau A, Lupien PJ, Thériault G _et al_. The response to long-term overfeeding in identical twins. _N Engl J Med_ 1990; 322: 1477–1482. Article  CAS  Google Scholar  * Calhoun


DA, Grassi G . Weight gain and hypertension: the chicken-egg question revisited. _J Hypertens_ 2004; 22: 1869–1871. Article  CAS  Google Scholar  * Ravussin E, Gautier JF . Metabolic


predictors of weight gain. _Int J Obes Relat Metab Disord_ 1999; 23 (Suppl 1): 37–41. Article  Google Scholar  * Pischon T, Sharma AM . Use of beta-blockers in obesity hypertension:


potential role of weight gain. _Obes Rev_ 2001; 2: 275–280. Article  CAS  Google Scholar  * Clement K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J _et al_. Genetic variation in


the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. _N Engl J Med_ 1995; 333: 352–354. Article  CAS  Google Scholar  * Strazzullo P,


Iacone R, Siani A, Cappuccio FP, Russo O, Barba G _et al_. Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction


with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. _J Hypertens_ 2001; 19: 399–406. Article  CAS  Google Scholar  * van Rossum CT, Hoebee B, Seidell


JC, Bouchard C, van Baak MA, de Groot CP _et al_. Genetic factors as predictors of weight gain in young adult Dutch men and women. _Int J Obes Relat Metab Disord_ 2002; 26: 517–528. Article


  CAS  Google Scholar  * Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Elkasabany A, Gustat J _et al_. Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal


changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. _Int J Obes Relat Metab Disord_ 2002; 26: 928–937. Article  CAS  Google Scholar  *


Koda M, Ando F, Niino N, Shimokata H, Miyasaka K, Funakoshi A . Association of cholecystokinin 1 receptor and beta3-adrenergic receptor polymorphisms with midlife weight gain. _Obes Res_


2004; 12: 1212–1216. Article  CAS  Google Scholar  * Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS . Interactive effects between polymorphisms in the


beta-adrenergic receptors and longitudinal changes in obesity. _Obes Res_ 2005; 13: 519–526. Article  CAS  Google Scholar  * Linne Y, Dahlman I, Hoffstedt J . beta1-Adrenoceptor gene


polymorphism predicts long-term changes in body weight. _Int J Obes (Lond)_ 2005; 29: 458–462. Article  CAS  Google Scholar  * Collins S, Cao W, Robidoux J . Learning new tricks from old


dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. _Mol Endocrinol_ 2004; 18: 2123–2131. Article  CAS  Google Scholar  * Hellstrom L, Rossner S,


Hagstrom-Toft E, Reynisdottir S . Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity–a metabolic predictor of weight loss in obese subjects. _Int J Obes Relat


Metab Disord_ 1997; 21: 314–320. Article  CAS  Google Scholar  * Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Arner P . Catecholamine resistance in fat cells of women with


upper-body obesity due to decreased expression of beta 2-adrenoceptors. _Diabetologia_ 1994; 37: 428–435. Article  CAS  Google Scholar  * Arner P, Arner O, Ostman J . The effect of local


anaesthetic agents on lipolysis by human adipose tissue. _Life Sci_ 1973; 13: 161–169. Article  CAS  Google Scholar  * Lonnqvist F, Krief S, Strosberg AD, Nyberg S, Emorine LJ, Arner P .


Evidence for a functional beta 3-adrenoceptor in man. _Br J Pharmacol_ 1993; 110: 929–936. Article  CAS  Google Scholar  * Shimizu M, Blaak EE, Lonnqvist F, Gafvels ME, Arner P . Agonist and


antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes. _Pharmacol Toxicol_ 1996; 78: 254–263. Article  CAS  Google Scholar  * Sennitt MV, Kaumann AJ,


Molenaar P, Beeley LJ, Young PW, Kelly J _et al_. The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right


atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities. _J Pharmacol Exp Ther_ 1998; 285: 1084–1095. CAS  PubMed  Google Scholar  * Hoffstedt J, Naslund


E, Arner P . Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells. _J Clin Endocrinol Metab_ 2002; 87: 3362–3367. CAS  PubMed  Google


Scholar  * Arner P, Hellmer J, Wennlund A, Ostman J, Engfeldt P . Adrenoceptor occupancy in isolated human fat cells and its relationship with lipolysis rate. _Eur J Pharmacol_ 1988; 146:


45–56. Article  CAS  Google Scholar  * Kenakin T . Drugs and receptors. An overview of the current state of knowledge. _Drugs_ 1990; 40: 666–687. Article  CAS  Google Scholar  * Engfeldt P,


Arner P, Ostman J . Influence of adipocyte isolation by collagenase on phosphodiesterase activity and lipolysis in man. _J Lipid Res_ 1980; 21: 443–448. CAS  PubMed  Google Scholar  *


Hoffstedt J, Poirier O, Thorne A, Lönnqvist F, Herrmann SM, Cambien F _et al_. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with


moderate obesity and altered receptor function. _Diabetes_ 1999; 48: 203–205. Article  CAS  Google Scholar  * Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE _et al_.


Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. _Nature_ 1984; 309: 163–165. Article  CAS  Google Scholar  * Sundquist K, Qvist J, Johansson SE, Sundquist J


. Increasing trends of obesity in Sweden between 1996/97 and 2000/01. _Int J Obes Relat Metab Disord_ 2004; 28: 254–261. Article  CAS  Google Scholar  * Hellmer J, Wahrenberg H, Arner P .


Stability over time of adrenergic sensitivity in isolated human fat cells. _Int J Obes Relat Metab Disord_ 1992; 16: 23–28. CAS  PubMed  Google Scholar  * Enocksson S, Shimizu M, Lonnqvist


F, Nordenstrom J, Arner P . Demonstration of an _in vivo_ functional beta 3-adrenoceptor in man. _J Clin Invest_ 1995; 95: 2239–2245. Article  CAS  PubMed Central  Google Scholar  * Krief S,


Lonnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P _et al_. Tissue distribution of beta 3-adrenergic receptor mRNA in man. _J Clin Invest_ 1993; 91: 344–349. Article  CAS  PubMed


Central  Google Scholar  * Weyer C, Tataranni PA, Snitker S, Danforth Jr E, Ravussin E . Increase in insulin action and fat oxidation after treatment with CL316,243, a highly selective


beta3-adrenoceptor agonist in humans. _Diabetes_ 1998; 47: 1555–1561. Article  CAS  Google Scholar  * Kuczmarski R, Flegal K, Campbell S, Johnson S . Increasing prevalence of overweight


among US adults: the National Health and Nutrition Examination Surveys 1960 to 1991. _JAMA_ 1994; 272: 205–211. Article  CAS  Google Scholar  * Spalding KL, Arner E, Westermark PO, Bernard


S, Buchholz BA, Bergmann O _et al_. Dynamics of fat cell turnover in humans. _Nature_ 2008; 453: 783–787. Article  CAS  Google Scholar  * Hollenga C, Brouwer F, Zaagsma J . Differences in


functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types. _Eur J Pharmacol_ 1991; 6: 325–330. Article  Google Scholar  * Tavernier G,


Barbe P, Galitzky J, Berlan M, Caput D, Lafontan M _et al_. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. _J Lipid Res_ 1996; 37: 87–97.


CAS  PubMed  Google Scholar  * Rosenbaum M, Malbon CC, Hirsch J, Leibel RL . Lack of beta 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. _J Clin Endocrinol Metab_


1993; 77: 352–355. CAS  PubMed  Google Scholar  * Hoffstedt J, Shimizu M, Sjöstedt S, Lönnqvist F . Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells. _Obes Res_


1995; 3: 447–457. Article  CAS  Google Scholar  * McConnaughey MM, Sheets KA, Davis J, Privette J, Hickner R, Christian B _et al_. Differences in beta-adrenergic receptor densities in


omental and subcutaneous adipose tissue from obese African American and Caucasian women. _Metabolism_ 2004; 53: 247–251. Article  CAS  Google Scholar  * Woods SC, Gotoh K, Clegg DJ . Gender


differences in the control of energy homeostasis. _Exp Biol Med_ 2003; 228: 1175–1180. Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS We are thankful to Kerstin Wåhlén,


Eva Sjölin, Katarina Hertel and Britt-Marie Leionhufvud for their skillful technical assistance. This study was supported by grants from Swedish Research Council, Novo Nordisk Foundation,


Swedish Diabetes Foundation and Old Female Servant Foundation. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department for Endocrinology, Metabolism and Diabetes, Karolinska University


Hospital Huddinge, Stockholm, Sweden D Andersson, H Wahrenberg & P Löfgren * Department of Medicine, Karolinska Institutet, Stockholm, Sweden D Andersson, H Wahrenberg & P Löfgren


Authors * D Andersson View author publications You can also search for this author inPubMed Google Scholar * H Wahrenberg View author publications You can also search for this author


inPubMed Google Scholar * P Löfgren View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to P Löfgren. RIGHTS AND


PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Andersson, D., Wahrenberg, H. & Löfgren, P. β3-Adrenoceptor function and long-term changes in body weight. _Int


J Obes_ 33, 662–668 (2009). https://doi.org/10.1038/ijo.2009.54 Download citation * Received: 26 October 2008 * Revised: 25 February 2009 * Accepted: 07 March 2009 * Published: 14 April 2009


* Issue Date: June 2009 * DOI: https://doi.org/10.1038/ijo.2009.54 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a


shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * fat cells * lipolysis *


terbutaline * dobutamine * CGP 12177